Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» EMA panel recommends that use of Actelion's Uptravi may continue
EMA panel recommends that use of Actelion's Uptravi may continue
EMA panel recommends that use of Actelion's Uptravi may continue
Submitted by
admin
on February 11, 2017 - 12:32pm
Source:
Yahoo/Reuters
News Tags:
Europe
Actelion
Uptravi
pulmonary arterial hypertension
PAH
France
Headline:
EMA panel recommends that use of Actelion's Uptravi may continue
Do Not Allow Advertisers to Use My Personal information
